Zhong-Hai Zhou

411 total citations
19 papers, 354 citations indexed

About

Zhong-Hai Zhou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Zhong-Hai Zhou has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Zhong-Hai Zhou's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Zhong-Hai Zhou is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Zhong-Hai Zhou collaborates with scholars based in China. Zhong-Hai Zhou's co-authors include Fuxing Chen, Junquan Liu, Xiaoting Lv, Yongqiang Chen, Lu Zheng, Xiaoting Lu, Xiaoting Wu, Tao Wang, Ling Chen and Juan Zhang and has published in prestigious journals such as Annals of Oncology, Experimental Cell Research and Materials & Design.

In The Last Decade

Zhong-Hai Zhou

19 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhong-Hai Zhou China 12 152 96 58 54 35 19 354
Chin-Mu Hsu Taiwan 16 163 1.1× 54 0.6× 44 0.8× 35 0.6× 41 1.2× 21 478
Liting Huang China 12 236 1.6× 90 0.9× 41 0.7× 27 0.5× 48 1.4× 29 484
Xue Hu China 13 184 1.2× 66 0.7× 46 0.8× 30 0.6× 49 1.4× 21 422
M. V. Gazzola Italy 7 105 0.7× 68 0.7× 53 0.9× 88 1.6× 15 0.4× 10 441
Chia‐Cheng Su Taiwan 11 201 1.3× 75 0.8× 33 0.6× 23 0.4× 56 1.6× 25 373
Rajaa Fakhoury Lebanon 10 82 0.5× 48 0.5× 47 0.8× 73 1.4× 23 0.7× 30 478
Zeynep Birsu Çinçin Türkiye 10 194 1.3× 50 0.5× 71 1.2× 17 0.3× 38 1.1× 14 355
MyongHak Ri China 11 230 1.5× 77 0.8× 108 1.9× 31 0.6× 89 2.5× 12 447
Susanne Tornhamre Sweden 12 94 0.6× 55 0.6× 38 0.7× 44 0.8× 30 0.9× 15 359
Dinglai Yu China 8 234 1.5× 33 0.3× 81 1.4× 18 0.3× 63 1.8× 11 387

Countries citing papers authored by Zhong-Hai Zhou

Since Specialization
Citations

This map shows the geographic impact of Zhong-Hai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong-Hai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong-Hai Zhou more than expected).

Fields of papers citing papers by Zhong-Hai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong-Hai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong-Hai Zhou. The network helps show where Zhong-Hai Zhou may publish in the future.

Co-authorship network of co-authors of Zhong-Hai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong-Hai Zhou. A scholar is included among the top collaborators of Zhong-Hai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong-Hai Zhou. Zhong-Hai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lu, Xiaoting, et al.. (2025). Isolation of daucosterol from Polygonum capitatum and its antitumor activity against gastric cancer BGC-823 cells. South African Journal of Botany. 179. 1–10. 1 indexed citations
2.
Yang, Jie, et al.. (2023). In vitro study on antitumor activity of aurantiamide acetate extracted from Polygonum capitatum. South African Journal of Botany. 159. 280–289. 2 indexed citations
3.
Chen, Ling, et al.. (2023). Immunopotentiation effects of apigenin on NK cell proliferation and killing pancreatic cancer cells. International Journal of Immunopathology and Pharmacology. 37. 1200381270–1200381270. 20 indexed citations
5.
Zhou, Zhong-Hai, et al.. (2018). LncRNA BCAR4 up-regulates EGFR and thus promotes human thyrocyte proliferation. Neoplasma. 66(2). 222–231. 6 indexed citations
6.
Zhou, Zhong-Hai, et al.. (2018). Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells. Immunopharmacology and Immunotoxicology. 40(2). 107–116. 29 indexed citations
7.
8.
Guo, Fengxiang, Wei Wang, Wenhui Yu, et al.. (2017). Enhanced nucleation and refinement of eutectic Si by high number-density nano-particles in Al–10Si–0.5Sb alloys. Materials & Design. 117. 382–389. 19 indexed citations
9.
Chen, Yongqiang, Lu Zheng, Zhong-Hai Zhou, et al.. (2017). Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer. Experimental Cell Research. 362(1). 63–71. 24 indexed citations
10.
Zhou, Yu, Junquan Liu, Zhong-Hai Zhou, et al.. (2015). Enhancement of CD3AK cell proliferation and killing ability by α-Thujone. International Immunopharmacology. 30. 57–61. 15 indexed citations
11.
Hua, Rong, Yong-Mei Zhang, Fuxing Chen, et al.. (2014). Decreased levels of perforin-positive lymphocytes are associated with posttraumatic complications in patients with major trauma. Injury. 45(12). 2089–2095. 6 indexed citations
12.
Chen, Yongqiang, Lu Zheng, Junquan Liu, et al.. (2014). Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. International Immunopharmacology. 21(2). 447–455. 77 indexed citations
13.
Wu, Xiaoting, Junquan Liu, Xiaoting Lu, et al.. (2013). The enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells. International Immunopharmacology. 16(2). 332–340. 49 indexed citations
14.
Zhou, Zhong-Hai, Fuxing Chen, Wenrong Xu, et al.. (2013). Enhancement effect of dihydroartemisinin on human γδ T cell proliferation and killing pancreatic cancer cells. International Immunopharmacology. 17(3). 850–857. 33 indexed citations
15.
Wang, Weisong, Lihua Li, Zhong-Hai Zhou, Junjie Gao, & Ying-hao SUN. (2013). Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease. Experimental and Therapeutic Medicine. 6(6). 1527–1531. 11 indexed citations
16.
Hua, Rong, et al.. (2013). [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].. PubMed. 25(8). 489–92. 4 indexed citations
17.
Liu, Gang, Xiaoting Wu, Fuxing Chen, et al.. (2012). The effect of Phloretin on human γδ T cells killing colon cancer SW-1116 cells. International Immunopharmacology. 15(1). 6–14. 23 indexed citations
18.
Hua, Rong, Shanshan Mao, Yong-Mei Zhang, et al.. (2012). Effects of pituitary adenylate cyclase activating polypeptide on CD4+/CD8+T cell levels after traumatic brain injury in a rat model. World Journal of Emergency Medicine. 3(4). 294–294. 10 indexed citations
19.
Chen, Fuxing, Junquan Liu, Guolong Zhang, et al.. (2002). [Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor].. PubMed. 21(7). 797–801. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026